Inventor
CHU-BIN LIAO
Inventor
TW
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds15%
C07KPeptides15%
C12NMicroorganisms or enzymes8%
PatentTitleYear
12,448,394Heterocyclic pyrazole derivatives as type III receptor tyrosine kinase inhibitors202512,187,806Anti-CD73 antibodies and use thereof202512,043,668Anti-human CSF-1R antibody and uses thereof202411,407,757Heterocycle compounds as Tyro3, Axl and MerTK (TAM) family of receptor tyrosine kinase inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to DEV CT BIOTECHNOLOGY (4)· patent assignee history
2022–2025Based in TW· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DEV CT BIOTECHNOLOGY | 4 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| TW | 4 | 2022–2025 |